148 related articles for article (PubMed ID: 38103076)
1. Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy.
Udagawa S; Osumi H; Kozuki R; Ooki A; Wakatsuki T; Kurihara N; Mukai T; Yamaguchi T; Akiyoshi T; Fukunaga Y; Yamaguchi K; Shinozaki E
Surg Today; 2023 Dec; ():. PubMed ID: 38103076
[TBL] [Abstract][Full Text] [Related]
2. Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.
Pu H; Yang W; Liu M; Pang X; Chen Y; Xiong Q
Sci Rep; 2024 Mar; 14(1):6889. PubMed ID: 38519578
[TBL] [Abstract][Full Text] [Related]
3. Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
Yoshino K; Osumi H; Ito H; Kamiimabeppu D; Ooki A; Wakatsuki T; Shimozaki K; Nakayama I; Ogura M; Takahari D; Chin K; Oba A; Ono Y; Sato T; Inoue Y; Takahashi Y; Yamaguchi K; Shinozaki E
Ann Surg Oncol; 2022 Dec; 29(13):8385-8393. PubMed ID: 35974233
[TBL] [Abstract][Full Text] [Related]
4. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.
Konishi T; Shimada Y; Hsu M; Tufts L; Jimenez-Rodriguez R; Cercek A; Yaeger R; Saltz L; Smith JJ; Nash GM; Guillem JG; Paty PB; Garcia-Aguilar J; Gonen M; Weiser MR
JAMA Oncol; 2018 Mar; 4(3):309-315. PubMed ID: 29270608
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
[TBL] [Abstract][Full Text] [Related]
7. High postoperative carcinoembryonic antigen as an indicator of high-risk stage II colon cancer.
Morimoto Y; Takahashi H; Arita A; Itakura H; Fujii M; Sekido Y; Hata T; Fujino S; Ogino T; Miyoshi N; Uemura M; Matsuda C; Yamamoto H; Mizushima T; Doki Y; Eguchi H
Oncol Lett; 2022 May; 23(5):167. PubMed ID: 35414828
[TBL] [Abstract][Full Text] [Related]
8. Persistent high levels of carcinoembryonic antigen after tumor resection are associated with poorer survival outcomes in patients with resected colon cancer.
Muñoz-Montaño WR; López-Basave HN; Castillo-Morales A; Castillo-Morales C; Sánchez-Trejo K; Catalán R; Díaz-Romero C; Lino-Silva LS; Maliachi-Díaz A; Ruiz-García E; Herrera-Martínez M; Calderillo-Ruíz G
BMC Cancer; 2023 Jul; 23(1):678. PubMed ID: 37468881
[TBL] [Abstract][Full Text] [Related]
9. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer.
Suenaga Y; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
World J Gastrointest Oncol; 2019 Jan; 11(1):17-27. PubMed ID: 30984347
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis.
Zhou H; Wang S; Cai Z; Qiu E; Chen Q; Rao X; Han S; Li Z
Int J Colorectal Dis; 2022 Dec; 37(12):2481-2489. PubMed ID: 36334109
[TBL] [Abstract][Full Text] [Related]
12. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
13. Prognostic stratification of pathological node-negative lung adenocarcinoma by carcinoembryonic antigen level.
Batmunkh K; Cho S; Yum S; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2020 Jun; 30(6):820-826. PubMed ID: 32221597
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study.
Ma L; Li W; Liu N; Ding Z; Cai J; Zhang Y
Updates Surg; 2022 Jun; 74(3):999-1009. PubMed ID: 35322387
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.
Nakamura Y; Shida D; Tanabe T; Takamizawa Y; Imaizumi J; Ahiko Y; Sakamoto R; Moritani K; Tsukamoto S; Kanemitsu Y
Cancer Med; 2020 Jan; 9(2):653-662. PubMed ID: 31799750
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Preoperative and Postoperative Serum Carcinoembryonic Antigen and Prognosis of Patients with Stage I-III Rectal Cancer: A Retrospective Study of a Multicentre Cohort of 1022 Rectal Cancer Patients.
Pu H; Xie P; Chen Y; Zhao Y; Ye X; Lu G; Zhang D; Li Z
Cancer Manag Res; 2021; 13():2643-2651. PubMed ID: 33776482
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
19. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer.
Murono K; Kazama S; Yamaguchi H; Kawai K; Ishihara S; Sunami E; Kitayama J; Satoh Y; Kurihara M; Yatomi Y; Watanabe T
Surgery; 2015 Feb; 157(2):322-30. PubMed ID: 25311262
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the decreased rate of perioperative serum carcinoembryonic antigen level in the patients with colon cancer after a curative resection.
Jung TD; Yoo JH; Lee MJ; Park HK; Shin JH; An MS; Ha TK; Kim KH; Bae KB; Kim TH; Choi CS; Oh MK; Hong KH
Ann Coloproctol; 2013 Jun; 29(3):115-22. PubMed ID: 23862129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
